Join

Compare · AVTR vs OLK

AVTR vs OLK

Side-by-side comparison of Avantor Inc. (AVTR) and Olink Holding AB (OLK): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AVTR and OLK operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • AVTR carries a market cap of $6.25B.
  • AVTR has hit the wire 14 times in the past 4 weeks while OLK has been quiet.
  • AVTR has more recent analyst coverage (25 ratings vs 3 for OLK).
MetricAVTROLK
Company
Avantor Inc.
Olink Holding AB
Price
$9.15+8.93%
$26.01+0.04%
Market cap
$6.25B
-
1M return
+16.41%
-
1Y return
-29.75%
-
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NYSE
NASDAQ
IPO
2019
2021
News (4w)
14
0
Recent ratings
25
3
AVTR

Avantor Inc.

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

OLK

Olink Holding AB

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.

Latest AVTR

Latest OLK